George M. Whitesides's most recent trade in Theravance Biopharma Inc was a trade of 9,828 Ordinary Shares done . Disclosure was reported to the exchange on April 27, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Theravance Biopharma Inc | George M. Whitesides | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 9,828 | 9,828 (0%) | 0% | 0 | Ordinary Shares | |
Theravance Biopharma Inc | George M. Whitesides | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,000 | 6,000 | - | - | Share Option (Right to Buy) |